tirzepatide weight loss clinical trial for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide vs Semaglutide in Ponte

Phase II Clinical Trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Hanma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc

Public knowledge of dehydration and fluid intake practices: variation by participants' characteristics

men should seek participation in a registered clinical trial via NIHR Be Part of Research, or discuss currently NICE-approved treatments such as semaglutide or tirzepatide with their GP

Resources We Trust Cleveland Clinic: GLP-1 Agonists Brown University Health: Fact and Fictions About Weight Loss Medications I Am Taking a GLP-1 Weight-Loss Medication What Should I Know